Barbara Wappenschmidt
Overview
Explore the profile of Barbara Wappenschmidt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
5999
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Coignard J, Lush M, Beesley J, OMara T, Dennis J, Tyrer J, et al.
Nat Commun
. 2021 May;
12(1):2986.
PMID: 33990587
A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23162-4.
22.
Coignard J, Lush M, Beesley J, OMara T, Dennis J, Tyrer J, et al.
Nat Commun
. 2021 Feb;
12(1):1078.
PMID: 33597508
Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers....
23.
Lepkes L, Kayali M, Blumcke B, Weber J, Suszynska M, Schmidt S, et al.
Cancers (Basel)
. 2021 Jan;
13(1).
PMID: 33401422
The identification of germline copy number variants (CNVs) by targeted next-generation sequencing (NGS) frequently relies on in silico CNV prediction tools with unknown sensitivities. We investigated the performances of four...
24.
Borde J, Ernst C, Wappenschmidt B, Niederacher D, Weber-Lassalle K, Schmidt G, et al.
J Natl Cancer Inst
. 2020 Dec;
113(7):893-899.
PMID: 33372680
Background: Genome-wide association studies suggest that the combined effects of breast cancer (BC)-associated single nucleotide polymorphisms (SNPs) can improve BC risk stratification using polygenic risk scores (PRSs). The performance of...
25.
Muranen T, Khan S, Fagerholm R, Aittomaki K, Cunningham J, Dennis J, et al.
NPJ Breast Cancer
. 2020 Sep;
6:44.
PMID: 32964118
Germline genetic variation has been suggested to influence the survival of breast cancer patients independently of tumor pathology. We have studied survival associations of genetic variants in two etiologically unique...
26.
Barnes D, Rookus M, McGuffog L, Leslie G, Mooij T, Dennis J, et al.
Genet Med
. 2020 Jul;
22(10):1653-1666.
PMID: 32665703
Purpose: We assessed the associations between population-based polygenic risk scores (PRS) for breast (BC) or epithelial ovarian cancer (EOC) with cancer risks for BRCA1 and BRCA2 pathogenic variant carriers. Methods:...
27.
Silvestri V, Leslie G, Barnes D, Agnarsson B, Aittomaki K, Alducci E, et al.
JAMA Oncol
. 2020 Jul;
6(8):1218-1230.
PMID: 32614418
Importance: The limited data on cancer phenotypes in men with germline BRCA1 and BRCA2 pathogenic variants (PVs) have hampered the development of evidence-based recommendations for early cancer detection and risk...
28.
Zhang H, Ahearn T, Lecarpentier J, Barnes D, Beesley J, Qi G, et al.
Nat Genet
. 2020 May;
52(6):572-581.
PMID: 32424353
Breast cancer susceptibility variants frequently show heterogeneity in associations by tumor subtype. To identify novel loci, we performed a genome-wide association study including 133,384 breast cancer cases and 113,789 controls,...
29.
Wappenschmidt B, Hauke J, Faust U, Niederacher D, Wiesmuller L, Schmidt G, et al.
Geburtshilfe Frauenheilkd
. 2020 Apr;
80(4):410-429.
PMID: 32322110
More than ten years ago, the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC) set up a panel of experts (VUS Task Force) which was tasked with reviewing the...
30.
Feng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu-Full Z, et al.
Genet Epidemiol
. 2020 Mar;
44(5):442-468.
PMID: 32115800
Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by integrating data from expression quantitative loci and genome-wide association studies (GWAS), but analyses of breast cancer subtype-specific associations...